Motif ID: Spi1
Z-value: 1.342
Transcription factors associated with Spi1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Spi1 | ENSMUSG00000002111.8 | Spi1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Spi1 | mm10_v2_chr2_+_91082362_91082390 | -0.46 | 3.0e-05 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.9 | 31.4 | GO:0051311 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
| 6.4 | 32.0 | GO:0021905 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
| 4.1 | 4.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
| 3.1 | 12.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 2.8 | 8.5 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 2.8 | 14.1 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
| 2.8 | 8.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 2.5 | 10.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 2.5 | 14.7 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 2.4 | 7.2 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 2.3 | 7.0 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 2.1 | 12.4 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 2.0 | 20.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 2.0 | 9.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
| 1.9 | 7.6 | GO:1903416 | response to glycoside(GO:1903416) |
| 1.9 | 5.6 | GO:0006601 | creatine metabolic process(GO:0006600) creatine biosynthetic process(GO:0006601) |
| 1.8 | 5.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.8 | 7.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
| 1.7 | 12.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 1.7 | 8.5 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 1.7 | 15.2 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 1.6 | 4.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.6 | 4.9 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 1.6 | 8.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 1.6 | 4.8 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 1.6 | 4.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.5 | 4.4 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.5 | 11.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.5 | 2.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.4 | 7.2 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
| 1.4 | 4.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.4 | 10.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 1.4 | 13.5 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 1.3 | 2.7 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
| 1.3 | 4.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 1.3 | 9.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 1.3 | 3.9 | GO:0060023 | soft palate development(GO:0060023) |
| 1.3 | 3.9 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 1.3 | 1.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.3 | 1.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 1.3 | 3.8 | GO:0070488 | neutrophil aggregation(GO:0070488) |
| 1.2 | 5.0 | GO:2000256 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
| 1.2 | 3.6 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
| 1.2 | 3.6 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 1.2 | 4.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.1 | 6.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.1 | 3.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 1.1 | 5.5 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 1.1 | 7.7 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 1.1 | 9.8 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 1.1 | 7.6 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.1 | 3.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 1.1 | 3.2 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
| 1.1 | 4.3 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 1.1 | 3.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 1.0 | 4.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 1.0 | 2.1 | GO:0001757 | somite specification(GO:0001757) |
| 1.0 | 5.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 1.0 | 3.0 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
| 1.0 | 3.0 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) axial mesoderm morphogenesis(GO:0048319) |
| 1.0 | 2.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 1.0 | 3.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 1.0 | 2.9 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 1.0 | 6.8 | GO:0048102 | autophagic cell death(GO:0048102) |
| 1.0 | 4.8 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 1.0 | 1.9 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
| 1.0 | 1.9 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 1.0 | 3.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.9 | 5.6 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.9 | 4.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.9 | 5.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.9 | 0.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.9 | 6.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.9 | 7.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.9 | 5.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.9 | 3.6 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.9 | 8.0 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.9 | 3.5 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.9 | 6.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.9 | 0.9 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.9 | 7.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.9 | 4.3 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.9 | 3.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.8 | 1.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.8 | 3.4 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.8 | 3.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.8 | 7.3 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
| 0.8 | 1.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.8 | 2.4 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.8 | 1.6 | GO:2000851 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.8 | 2.4 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.8 | 3.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.8 | 3.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.8 | 2.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.8 | 8.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.8 | 3.1 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
| 0.8 | 0.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.8 | 2.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.7 | 2.2 | GO:1990046 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.7 | 3.7 | GO:0060690 | epithelial cell differentiation involved in salivary gland development(GO:0060690) |
| 0.7 | 0.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.7 | 7.4 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.7 | 11.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.7 | 1.5 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.7 | 6.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.7 | 1.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.7 | 2.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.7 | 2.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.7 | 2.1 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.7 | 5.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.7 | 5.0 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 | 1.4 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
| 0.7 | 2.1 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 0.7 | 2.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.7 | 9.7 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.7 | 2.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.7 | 6.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.7 | 4.8 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.7 | 5.5 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.7 | 2.7 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
| 0.7 | 2.0 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.7 | 2.7 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.7 | 2.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.7 | 5.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.7 | 2.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.7 | 2.0 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.7 | 7.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.7 | 1.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.6 | 1.3 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.6 | 4.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.6 | 11.5 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.6 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.6 | 2.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.6 | 8.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.6 | 11.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.6 | 3.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.6 | 1.8 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.6 | 4.3 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.6 | 1.8 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil activation(GO:1902566) |
| 0.6 | 3.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.6 | 3.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.6 | 1.2 | GO:2000790 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.6 | 1.2 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 0.6 | 5.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.6 | 0.6 | GO:0019081 | viral translation(GO:0019081) IRES-dependent viral translational initiation(GO:0075522) |
| 0.6 | 2.3 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.6 | 4.6 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 0.6 | 4.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.6 | 3.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.6 | 2.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.6 | 1.7 | GO:0032240 | RNA import into nucleus(GO:0006404) mRNA export from nucleus in response to heat stress(GO:0031990) negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.6 | 1.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.6 | 3.9 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.6 | 1.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.6 | 3.9 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
| 0.6 | 11.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.6 | 1.7 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
| 0.5 | 0.5 | GO:0060032 | notochord regression(GO:0060032) |
| 0.5 | 12.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.5 | 0.5 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.5 | 1.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.5 | 2.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.5 | 0.5 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
| 0.5 | 1.6 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 0.5 | 3.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.5 | 1.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.5 | 12.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.5 | 3.1 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.5 | 5.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.5 | 0.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.5 | 1.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.5 | 4.6 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.5 | 3.1 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.5 | 5.7 | GO:0030432 | peristalsis(GO:0030432) |
| 0.5 | 2.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.5 | 0.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.5 | 6.1 | GO:0060013 | righting reflex(GO:0060013) |
| 0.5 | 1.5 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.5 | 3.5 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.5 | 1.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 0.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.5 | 1.0 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.5 | 1.5 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 | 2.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.5 | 2.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 | 1.9 | GO:0006272 | DNA replication, synthesis of RNA primer(GO:0006269) leading strand elongation(GO:0006272) |
| 0.5 | 1.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 | 1.0 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
| 0.5 | 6.2 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.5 | 2.8 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.5 | 1.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.5 | 0.5 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.4 | 1.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.4 | 3.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.4 | 3.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.4 | 4.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.4 | 0.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.4 | 1.3 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.4 | 1.7 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 0.4 | 2.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 2.1 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.4 | 0.8 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.4 | 2.9 | GO:0046549 | phenol-containing compound catabolic process(GO:0019336) retinal cone cell development(GO:0046549) |
| 0.4 | 1.6 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.4 | 1.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 1.2 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.4 | 2.4 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.4 | 5.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.4 | 3.2 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.4 | 3.2 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.4 | 5.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.4 | 1.2 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.4 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.4 | 1.2 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 | 2.0 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.4 | 0.8 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 | 1.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.4 | 2.7 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.4 | 0.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.4 | 0.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
| 0.4 | 1.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 0.4 | 2.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 | 1.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.4 | 2.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.4 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 | 1.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.4 | 1.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.4 | 2.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 0.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.4 | 11.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.4 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.4 | 1.8 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.4 | 2.9 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.4 | 1.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.4 | 3.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.4 | 2.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.4 | 0.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) positive regulation of sequestering of triglyceride(GO:0010890) sequestering of triglyceride(GO:0030730) |
| 0.4 | 1.8 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
| 0.4 | 4.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.4 | 0.7 | GO:1900133 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.3 | 3.1 | GO:0007281 | germ cell development(GO:0007281) |
| 0.3 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 | 0.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.3 | 1.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.3 | 1.0 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.3 | 1.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.3 | 1.0 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.3 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.3 | 12.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.3 | 1.0 | GO:0045014 | ectoderm formation(GO:0001705) detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) detection of glucose(GO:0051594) |
| 0.3 | 2.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 | 1.0 | GO:1903061 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.3 | 1.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.3 | 1.6 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 4.4 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
| 0.3 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 0.9 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.3 | 3.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 0.9 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 | 1.2 | GO:0042117 | monocyte activation(GO:0042117) |
| 0.3 | 0.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.3 | 0.9 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.3 | 3.3 | GO:0048368 | lateral mesoderm development(GO:0048368) |
| 0.3 | 2.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.3 | 5.1 | GO:0071559 | response to transforming growth factor beta(GO:0071559) |
| 0.3 | 2.4 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.3 | 0.9 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.3 | 0.6 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.3 | 0.6 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.3 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 | 1.2 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.3 | 4.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.3 | 5.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.3 | 1.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.3 | 2.3 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) CD4-positive or CD8-positive, alpha-beta T cell lineage commitment(GO:0043369) |
| 0.3 | 0.6 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.3 | 1.4 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.3 | 1.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.3 | 0.9 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.3 | 0.9 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.3 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.3 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.3 | 1.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.3 | 7.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 1.7 | GO:0003383 | apical constriction(GO:0003383) |
| 0.3 | 1.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
| 0.3 | 2.8 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.3 | 1.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.3 | 0.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.3 | 2.7 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
| 0.3 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
| 0.3 | 0.5 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.3 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.3 | 1.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.3 | 2.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 | 3.4 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.3 | 1.6 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 0.3 | 2.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.3 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.3 | 0.5 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.3 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.3 | 1.3 | GO:1990839 | response to endothelin(GO:1990839) |
| 0.3 | 0.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.3 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 0.8 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.3 | 1.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.2 | 1.0 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.2 | 1.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.2 | 0.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 | 0.5 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
| 0.2 | 0.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.2 | 0.7 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.2 | 4.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
| 0.2 | 7.6 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 | 0.7 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 0.2 | 1.0 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 | 1.2 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.2 | 0.2 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
| 0.2 | 0.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
| 0.2 | 1.4 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.2 | 1.7 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 0.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 2.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.2 | 0.7 | GO:0097309 | cap1 mRNA methylation(GO:0097309) |
| 0.2 | 0.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.2 | 0.5 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
| 0.2 | 1.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.2 | 0.9 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.2 | 0.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.2 | 2.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.2 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.2 | 0.7 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.2 | 1.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.2 | 0.5 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 0.2 | 4.5 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.2 | 4.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 4.7 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.2 | 1.8 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 0.2 | 1.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 | 1.1 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 1.3 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 | 0.4 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.2 | 0.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 0.4 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 | 0.7 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.2 | 1.3 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 1.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.2 | 1.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.2 | 20.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.2 | 0.6 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.2 | 1.7 | GO:0060281 | regulation of oocyte development(GO:0060281) |
| 0.2 | 1.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.2 | 0.9 | GO:0048793 | pronephros development(GO:0048793) |
| 0.2 | 1.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.2 | 1.9 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.2 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.2 | 0.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.2 | 0.2 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.2 | 2.7 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.2 | 2.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 | 2.9 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 | 2.3 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.2 | 0.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 0.2 | 1.5 | GO:0023058 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.2 | 1.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 | 2.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 0.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.2 | 1.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 1.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.2 | 2.0 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.2 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 | 5.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.2 | 4.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 | 1.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 0.2 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.2 | 10.3 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
| 0.2 | 2.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.2 | 1.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 0.9 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.2 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.2 | 1.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 2.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.2 | 2.6 | GO:0070828 | heterochromatin organization(GO:0070828) |
| 0.2 | 2.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.2 | 2.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.2 | 1.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 2.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.2 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.2 | 6.5 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.2 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.2 | 3.2 | GO:0007520 | myoblast fusion(GO:0007520) |
| 0.2 | 4.8 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 | 6.1 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
| 0.2 | 1.0 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
| 0.2 | 0.2 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.2 | 1.0 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 | 0.8 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.2 | 0.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 1.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
| 0.2 | 1.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.2 | 1.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.2 | 0.7 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.2 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.2 | 0.5 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 | 1.1 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.2 | 2.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.2 | 2.2 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.2 | 1.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.2 | 0.5 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.2 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 0.5 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.2 | 0.6 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
| 0.2 | 0.6 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.2 | 2.1 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.2 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 1.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 1.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.1 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.1 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
| 0.1 | 1.6 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 1.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.4 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 4.2 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
| 0.1 | 0.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.6 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.7 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 2.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.3 | GO:0045658 | eosinophil differentiation(GO:0030222) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 | 1.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 | 0.6 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 | 1.0 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 | 0.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 | 0.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 3.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 | 0.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.1 | 0.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 | 1.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.1 | 0.5 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 1.4 | GO:0019363 | pyridine nucleotide biosynthetic process(GO:0019363) |
| 0.1 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 2.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 1.0 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.1 | 1.3 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 5.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 0.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.5 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.1 | 0.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 8.0 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 2.2 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.1 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 | 0.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
| 0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 1.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 | 1.1 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.5 | GO:0072362 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.5 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 4.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 1.4 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
| 0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 1.8 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 0.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 | 3.0 | GO:0009409 | response to cold(GO:0009409) |
| 0.1 | 0.1 | GO:1901568 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
| 0.1 | 0.2 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.1 | 1.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
| 0.1 | 1.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.1 | 2.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.1 | 3.7 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.1 | 0.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
| 0.1 | 0.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.1 | 0.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 1.0 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 1.3 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 0.4 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.6 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.1 | 1.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 | 3.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 0.1 | 1.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 | 0.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 0.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 1.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
| 0.1 | 2.0 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 2.8 | GO:0030901 | midbrain development(GO:0030901) |
| 0.1 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.1 | 0.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 0.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 | 0.7 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.1 | 0.8 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 | 0.6 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.1 | 0.1 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 | 0.6 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.1 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 2.5 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of exocyst localization(GO:0060178) |
| 0.1 | 1.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 1.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.1 | 1.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.2 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
| 0.1 | 0.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
| 0.1 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.8 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.1 | 1.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
| 0.1 | 0.1 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 1.1 | GO:0046697 | decidualization(GO:0046697) |
| 0.1 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.5 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.1 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 | 0.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.1 | 1.0 | GO:0045056 | transcytosis(GO:0045056) |
| 0.1 | 0.4 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
| 0.1 | 10.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 1.5 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
| 0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 2.3 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 2.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 1.4 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 2.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 1.2 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 1.0 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.1 | 0.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 0.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 | 1.0 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 1.3 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 0.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.5 | GO:0010259 | multicellular organism aging(GO:0010259) |
| 0.1 | 1.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.1 | 0.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 | 0.3 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.1 | 0.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
| 0.1 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 2.6 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.5 | GO:0045639 | positive regulation of myeloid cell differentiation(GO:0045639) |
| 0.1 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 2.0 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
| 0.1 | 0.6 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 | 0.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 1.5 | GO:0070613 | regulation of protein processing(GO:0070613) |
| 0.1 | 0.6 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 0.6 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
| 0.1 | 2.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.5 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
| 0.1 | 0.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.1 | 0.2 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 | 0.2 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.1 | 0.1 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 0.3 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.2 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.5 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.1 | 0.3 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
| 0.1 | 0.3 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.1 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 | 0.2 | GO:1903286 | regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 | 0.7 | GO:0048535 | lymph node development(GO:0048535) |
| 0.1 | 0.1 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 0.1 | 0.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 0.1 | 0.7 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.1 | 0.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.4 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.7 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.1 | 0.4 | GO:1903624 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 0.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.1 | 0.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.1 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 | 0.6 | GO:0045727 | positive regulation of translation(GO:0045727) |
| 0.0 | 0.7 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.0 | 0.1 | GO:0050904 | diapedesis(GO:0050904) |
| 0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 0.0 | 1.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.0 | 0.3 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.8 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 | 1.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.0 | 0.0 | GO:1904398 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) regulation of neuromuscular junction development(GO:1904396) positive regulation of neuromuscular junction development(GO:1904398) |
| 0.0 | 0.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 6.1 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.0 | 0.4 | GO:0048821 | erythrocyte development(GO:0048821) |
| 0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.1 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
| 0.0 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.0 | 0.1 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.0 | 0.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.0 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 2.1 | GO:0036503 | ERAD pathway(GO:0036503) |
| 0.0 | 1.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.2 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 1.7 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) |
| 0.0 | 3.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
| 0.0 | 0.5 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 | 0.9 | GO:0006260 | DNA replication(GO:0006260) |
| 0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 | 1.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 | 0.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 | 1.9 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.0 | 0.1 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 | 0.6 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.1 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.0 | 0.6 | GO:0043473 | pigmentation(GO:0043473) |
| 0.0 | 0.1 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
| 0.0 | 0.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.0 | 0.8 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
| 0.0 | 0.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 | 0.2 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.3 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 | 0.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.0 | 0.1 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
| 0.0 | 0.2 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.0 | 0.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.0 | 0.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 | 0.2 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.0 | 0.2 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.1 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.0 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.0 | GO:2000858 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) positive regulation of mineralocorticoid secretion(GO:2000857) regulation of aldosterone secretion(GO:2000858) positive regulation of aldosterone secretion(GO:2000860) |
| 0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 0.0 | 0.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.0 | 0.1 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
| 0.0 | 0.3 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.5 | 31.6 | GO:0072687 | meiotic spindle(GO:0072687) |
| 3.0 | 8.9 | GO:0071953 | elastic fiber(GO:0071953) |
| 2.8 | 8.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 2.4 | 9.6 | GO:0008623 | CHRAC(GO:0008623) |
| 2.3 | 13.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 2.3 | 11.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 1.8 | 7.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.7 | 5.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 1.6 | 8.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.6 | 4.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.6 | 4.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.4 | 4.1 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 1.4 | 4.1 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
| 1.3 | 1.3 | GO:0043219 | lateral loop(GO:0043219) |
| 1.2 | 7.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 1.2 | 3.7 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 1.2 | 7.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 1.1 | 12.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 1.1 | 4.2 | GO:0043293 | apoptosome(GO:0043293) |
| 1.0 | 5.0 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.9 | 2.8 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.9 | 2.8 | GO:0000801 | central element(GO:0000801) |
| 0.9 | 6.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.8 | 3.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.8 | 3.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.7 | 2.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.7 | 7.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.7 | 4.7 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.7 | 5.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.7 | 9.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.7 | 2.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.6 | 3.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.6 | 1.9 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.6 | 2.6 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.6 | 5.7 | GO:0030478 | actin cap(GO:0030478) |
| 0.6 | 2.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.6 | 13.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.6 | 1.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.6 | 12.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.6 | 4.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.6 | 1.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.5 | 3.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.5 | 7.0 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.5 | 2.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.5 | 3.2 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.5 | 2.0 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.4 | 1.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.4 | 1.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 1.7 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.4 | 2.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.4 | 2.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.4 | 1.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.4 | 9.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.4 | 5.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.4 | 1.9 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.4 | 3.7 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 2.9 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.4 | 1.4 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.4 | 3.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.4 | 3.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.3 | 3.8 | GO:0045095 | keratin filament(GO:0045095) |
| 0.3 | 3.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.3 | 4.8 | GO:0042581 | specific granule(GO:0042581) |
| 0.3 | 2.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.3 | 3.7 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 2.7 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 1.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 5.0 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.3 | 1.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.3 | 2.6 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.3 | 1.8 | GO:0043256 | laminin complex(GO:0043256) |
| 0.3 | 0.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.3 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
| 0.3 | 3.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.3 | 2.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.3 | 2.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 3.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.3 | 16.7 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 1.6 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.3 | 1.3 | GO:0001740 | Barr body(GO:0001740) |
| 0.3 | 8.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 5.0 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.3 | 1.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.3 | 1.3 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 2.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 1.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.3 | 3.8 | GO:0042555 | MCM complex(GO:0042555) |
| 0.2 | 3.7 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.2 | 2.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 0.7 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.2 | 1.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 2.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.2 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.2 | 4.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 2.0 | GO:0002177 | manchette(GO:0002177) |
| 0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 12.0 | GO:0005657 | replication fork(GO:0005657) |
| 0.2 | 0.7 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 1.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 7.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.2 | 0.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.2 | 2.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.2 | 1.7 | GO:0000922 | spindle pole(GO:0000922) |
| 0.2 | 3.2 | GO:0031105 | septin complex(GO:0031105) |
| 0.2 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.2 | 1.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 2.1 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 1.6 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.2 | 2.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 4.7 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.2 | 4.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.2 | 0.8 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
| 0.2 | 1.4 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.2 | 79.6 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.2 | 1.2 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.2 | 0.8 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 1.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.2 | 1.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.2 | 0.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.2 | 13.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 0.2 | 28.9 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.2 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.2 | 1.8 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.2 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 2.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.2 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.2 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.2 | 2.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.2 | 3.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.2 | 0.3 | GO:0070820 | tertiary granule(GO:0070820) |
| 0.2 | 2.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.2 | 4.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.2 | 1.8 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 13.1 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 4.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.1 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.1 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 3.0 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 4.0 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 1.8 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 0.1 | GO:0033202 | DNA helicase complex(GO:0033202) |
| 0.1 | 0.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.1 | 9.5 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.1 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 5.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 4.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
| 0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.7 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 3.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.1 | 1.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 0.5 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.1 | 0.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 1.1 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.4 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.1 | 0.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.1 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.1 | 7.6 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.5 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 3.5 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.4 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) lumenal side of membrane(GO:0098576) |
| 0.1 | 0.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 4.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 3.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 1.3 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 0.3 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.3 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.1 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 1.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 1.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 10.8 | GO:0000785 | chromatin(GO:0000785) |
| 0.1 | 0.5 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 4.3 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 1.5 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.1 | 0.4 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 12.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 9.4 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 3.8 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 1.6 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.1 | 0.5 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 0.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 2.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 2.5 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.1 | 0.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 1.6 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 121.0 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.1 | 0.4 | GO:0030880 | RNA polymerase complex(GO:0030880) |
| 0.1 | 0.9 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.1 | 0.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.4 | GO:0030286 | dynein complex(GO:0030286) |
| 0.0 | 0.1 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.0 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.0 | 0.1 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 2.3 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 0.1 | GO:0098830 | presynaptic endosome(GO:0098830) |
| 0.0 | 0.9 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 0.2 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.0 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.0 | 0.9 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 1.2 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 5.1 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.4 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
| 0.0 | 0.3 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.0 | 0.8 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.1 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.3 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.0 | 1.1 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.0 | 0.6 | GO:0030496 | midbody(GO:0030496) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 12.0 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
| 2.7 | 16.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 2.6 | 7.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 2.1 | 8.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 2.1 | 6.4 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 2.0 | 5.9 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 1.9 | 5.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 1.9 | 41.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 1.7 | 10.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 1.6 | 9.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 1.5 | 6.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.4 | 4.2 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
| 1.4 | 4.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 1.3 | 3.8 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 1.2 | 3.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 1.2 | 3.6 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 1.2 | 3.5 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
| 1.2 | 7.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 1.1 | 6.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 1.1 | 10.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 1.1 | 3.2 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
| 1.0 | 3.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 1.0 | 6.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.0 | 5.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.0 | 4.0 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 1.0 | 3.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.9 | 3.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.9 | 6.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.9 | 3.6 | GO:0042806 | fucose binding(GO:0042806) |
| 0.9 | 3.6 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.9 | 2.7 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.9 | 2.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.9 | 3.5 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 0.9 | 7.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.8 | 10.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.8 | 5.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.8 | 2.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.8 | 8.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.8 | 11.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.8 | 8.5 | GO:0008430 | selenium binding(GO:0008430) |
| 0.7 | 3.7 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.7 | 2.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.7 | 2.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.7 | 4.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.7 | 2.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
| 0.7 | 12.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.6 | 3.8 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.6 | 2.5 | GO:0035473 | lipase binding(GO:0035473) |
| 0.6 | 2.5 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
| 0.6 | 3.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.6 | 1.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.6 | 4.9 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.6 | 2.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.6 | 11.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.6 | 3.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.6 | 13.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.6 | 4.5 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.6 | 2.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.6 | 2.2 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.6 | 1.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.6 | 1.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.5 | 2.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.5 | 4.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.5 | 2.6 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.5 | 15.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.5 | 1.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.5 | 4.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.5 | 2.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.5 | 4.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.5 | 1.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.5 | 2.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 2.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) neuregulin binding(GO:0038132) |
| 0.5 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.5 | 6.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.5 | 1.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.5 | 4.1 | GO:0032564 | dATP binding(GO:0032564) |
| 0.5 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.5 | 6.8 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.5 | 4.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.4 | 3.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.4 | 1.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.4 | 3.0 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.4 | 5.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 13.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.4 | 1.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.4 | 9.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.4 | 2.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.4 | 3.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.4 | 2.0 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 1.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.4 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.4 | 1.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 3.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.4 | 1.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 0.4 | 3.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.4 | 5.7 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.4 | 2.3 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.4 | 2.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.4 | 0.4 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.4 | 1.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 1.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.3 | 1.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 2.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.3 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 4.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 1.4 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 1.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.3 | 1.7 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.3 | 3.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.3 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.3 | 1.0 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.3 | 11.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 5.5 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.3 | 4.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.3 | 0.9 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.3 | 0.9 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 1.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.3 | 0.9 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.3 | 1.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.3 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.3 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.3 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 1.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.3 | 4.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.3 | 5.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.3 | 4.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.3 | 0.6 | GO:0070976 | TIR domain binding(GO:0070976) |
| 0.3 | 10.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.3 | 4.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.3 | 2.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.3 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
| 0.3 | 2.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.3 | 4.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.3 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.3 | 2.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.3 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) C-X-C chemokine binding(GO:0019958) |
| 0.3 | 4.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.3 | 6.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.3 | 7.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.3 | 1.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.3 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.3 | 3.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.3 | 1.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 3.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 1.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 5.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 1.0 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.2 | 2.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 1.2 | GO:0019961 | interferon binding(GO:0019961) |
| 0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.2 | 4.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 2.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 1.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.7 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.2 | 2.8 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.2 | 8.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.2 | 1.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 2.5 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.2 | 0.5 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.2 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.2 | 2.7 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.2 | 0.9 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 10.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.2 | 0.7 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 1.5 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.2 | 4.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.2 | 2.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
| 0.2 | 0.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.2 | 0.6 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.2 | 0.4 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
| 0.2 | 4.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.2 | 4.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 0.2 | 17.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.2 | 4.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.2 | 2.6 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.2 | 4.6 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 1.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.2 | 0.6 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.2 | 0.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.2 | 3.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 1.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.2 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.2 | 4.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 8.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 8.9 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.2 | 0.7 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.2 | 0.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.2 | 0.5 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.2 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.2 | 0.5 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 4.1 | GO:0042805 | actinin binding(GO:0042805) |
| 0.2 | 3.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 1.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 0.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.2 | 7.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 1.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.2 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.2 | 1.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.2 | 1.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.2 | 6.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 1.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.2 | 9.4 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.2 | 0.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.2 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 0.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.2 | 0.6 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 35.7 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 0.3 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 1.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 0.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.2 | 1.6 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 0.9 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.2 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 0.8 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 8.7 | GO:0002039 | p53 binding(GO:0002039) |
| 0.2 | 1.4 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.2 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 1.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.2 | 11.3 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.2 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 0.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.1 | 4.1 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 1.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 0.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.1 | 1.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.7 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 2.1 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.1 | 0.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.1 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.1 | 1.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 1.1 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 50.6 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 1.5 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 1.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.1 | 2.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.7 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 0.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.4 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 1.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.1 | 0.8 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.1 | 14.1 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.1 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.1 | 4.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 30.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 3.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.5 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
| 0.1 | 3.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.5 | GO:0008061 | chitin binding(GO:0008061) |
| 0.1 | 2.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 1.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 3.5 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.1 | 1.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.5 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 10.5 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.1 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.1 | 0.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.5 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.1 | 0.5 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 1.4 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
| 0.1 | 0.3 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 1.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 1.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.6 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.1 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 3.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 2.6 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 0.6 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.1 | 1.4 | GO:0015248 | sterol transporter activity(GO:0015248) cholesterol transporter activity(GO:0017127) |
| 0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.1 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.1 | 5.1 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 1.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 2.0 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.1 | 4.2 | GO:0008146 | sulfotransferase activity(GO:0008146) |
| 0.1 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.3 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.1 | 0.8 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.3 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
| 0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 9.8 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.4 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
| 0.1 | 2.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 1.6 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 2.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.1 | 2.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 1.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 5.6 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 0.9 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.1 | 0.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.1 | 0.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 1.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.1 | 1.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 1.6 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.1 | 9.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 0.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.1 | 0.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 1.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.1 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 1.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.4 | GO:0015197 | peptide transporter activity(GO:0015197) |
| 0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.1 | 0.2 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.1 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 1.5 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 1.9 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.7 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 43.1 | GO:0003677 | DNA binding(GO:0003677) |
| 0.0 | 6.1 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 1.5 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.0 | 0.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 3.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 2.1 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.0 | 0.8 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.0 | 0.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.0 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.0 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.0 | 0.3 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.0 | 0.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.0 | 3.9 | GO:0042623 | ATPase activity, coupled(GO:0042623) |
| 0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.5 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.0 | 0.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 2.3 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.1 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.0 | 0.3 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.0 | 0.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.0 | 0.3 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.0 | 0.6 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.0 | 1.0 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 0.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.0 | 0.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.0 | 0.2 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 0.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.0 | 0.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.0 | 0.3 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.0 | 0.0 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.0 | 0.2 | GO:0004620 | phospholipase activity(GO:0004620) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 2.7 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
| 0.9 | 41.3 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.7 | 20.2 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.7 | 35.8 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.5 | 12.4 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.5 | 11.2 | PID_RHOA_PATHWAY | RhoA signaling pathway |
| 0.4 | 3.1 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.4 | 6.3 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.4 | 0.4 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.4 | 26.4 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.4 | 3.3 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 10.5 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.4 | 12.1 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.4 | 3.8 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 9.3 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
| 0.4 | 10.0 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.4 | 14.3 | PID_ATM_PATHWAY | ATM pathway |
| 0.4 | 2.1 | PID_CXCR4_PATHWAY | CXCR4-mediated signaling events |
| 0.3 | 1.0 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.3 | 6.5 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
| 0.3 | 2.5 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 18.3 | PID_THROMBIN_PAR1_PATHWAY | PAR1-mediated thrombin signaling events |
| 0.3 | 6.8 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 9.5 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.3 | 17.1 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
| 0.3 | 12.3 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.2 | 3.7 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.2 | 14.2 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.2 | 15.1 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 3.8 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.2 | 14.7 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.2 | 1.3 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 1.1 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.2 | 8.0 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 15.4 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.2 | 2.9 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.2 | 1.6 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.2 | 1.1 | PID_IL5_PATHWAY | IL5-mediated signaling events |
| 0.2 | 5.7 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 1.9 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 0.5 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 2.4 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.1 | 1.9 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 3.2 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 4.1 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 0.4 | PID_IL8_CXCR2_PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.1 | 1.0 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.2 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 1.7 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.1 | 3.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 2.7 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
| 0.1 | 3.1 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 4.6 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 1.6 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.1 | 1.0 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
| 0.1 | 3.6 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.1 | 1.5 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.1 | 0.5 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 1.8 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.1 | 2.2 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 0.3 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 0.7 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.1 | 1.5 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.1 | 2.6 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.3 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 1.2 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.1 | 0.1 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
| 0.1 | 0.8 | PID_IL6_7_PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.5 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 1.0 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.6 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.4 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.3 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.2 | PID_CD40_PATHWAY | CD40/CD40L signaling |
| 0.0 | 0.9 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.2 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 0.3 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.3 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.0 | 0.1 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.1 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.0 | 0.1 | ST_GAQ_PATHWAY | G alpha q Pathway |
| 0.0 | 0.1 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.3 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.1 | PID_FOXO_PATHWAY | FoxO family signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 33.9 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.9 | 10.2 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.9 | 20.6 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.7 | 4.4 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.7 | 14.7 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.7 | 2.9 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.7 | 2.0 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.7 | 10.5 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.6 | 7.2 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.6 | 4.7 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.5 | 18.7 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.5 | 7.6 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.5 | 4.1 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
| 0.4 | 1.7 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 7.0 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.4 | 12.5 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.4 | 14.1 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.4 | 3.0 | REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.4 | 5.5 | REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.4 | 2.9 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.3 | 4.9 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.3 | 9.5 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.3 | 4.8 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.3 | 8.4 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 3.4 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 3.2 | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.3 | 14.1 | REACTOME_PI3K_AKT_ACTIVATION | Genes involved in PI3K/AKT activation |
| 0.2 | 3.7 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.2 | 1.2 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.2 | 3.6 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | Genes involved in Acyl chain remodelling of PE |
| 0.2 | 1.9 | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.2 | 2.3 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.2 | 24.4 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.2 | 1.3 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.2 | 2.7 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 10.5 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.2 | 6.3 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.2 | 2.0 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 3.2 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 4.0 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.2 | 2.3 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.2 | 1.2 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 2.0 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 7.4 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.2 | 5.1 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.1 | 4.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.3 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 3.7 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 2.2 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.1 | 1.7 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 2.7 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.5 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 1.8 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 1.5 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 2.9 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 5.0 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 3.0 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 0.1 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 1.1 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 3.6 | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 5.2 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 1.0 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.0 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.4 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 2.8 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.1 | 0.8 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.1 | 1.8 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.6 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.1 | 3.7 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 1.5 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.7 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.1 | 2.0 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 1.0 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 0.3 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 3.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 1.1 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.7 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 0.9 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 3.1 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 1.6 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 0.2 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 1.3 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.1 | 1.8 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.7 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 0.4 | REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 0.5 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 1.6 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 1.5 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.3 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 4.7 | REACTOME_MEIOSIS | Genes involved in Meiosis |
| 0.1 | 2.0 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.1 | 0.5 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 0.1 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.1 | 2.4 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.1 | 0.2 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 0.5 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 0.8 | REACTOME_PHOSPHORYLATION_OF_THE_APC_C | Genes involved in Phosphorylation of the APC/C |
| 0.0 | 0.5 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 2.0 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.7 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.7 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 3.0 | REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.0 | 1.2 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.3 | REACTOME_ELONGATION_ARREST_AND_RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 0.4 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.0 | 0.3 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 2.0 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.0 | 0.3 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.6 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 1.3 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.3 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 0.2 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.0 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.0 | 4.0 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.7 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.0 | 0.5 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 0.3 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.2 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.0 | 0.4 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.1 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.0 | 0.2 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
